Immunohistochemical analysis of 154 breast cancer patients and 42 women without tumor disease revealed that postmenopausal patients, hormone-receptor-positive patients, and histological ductal carcinoma patients had higher MMP-1 staining intensity and higher MMP3 staining percentages and intensities (158). This evidence concerns the gene NR4A1 and neoplasm.